0001415889-24-008352.txt : 20240318
0001415889-24-008352.hdr.sgml : 20240318
20240318195410
ACCESSION NUMBER: 0001415889-24-008352
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240314
FILED AS OF DATE: 20240318
DATE AS OF CHANGE: 20240318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Navratil Tomas
CENTRAL INDEX KEY: 0001920053
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37463
FILM NUMBER: 24760695
MAIL ADDRESS:
STREET 1: C/O GLAUKOS CORPORATION
STREET 2: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLAUKOS Corp
CENTRAL INDEX KEY: 0001192448
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GLAUKOS WAY
CITY: ALISO VIEJO
STATE: CA
ZIP: 92656
BUSINESS PHONE: 949-367-9600
MAIL ADDRESS:
STREET 1: 1 GLAUKOS WAY
CITY: ALISO VIEJO
STATE: CA
ZIP: 92656
FORMER COMPANY:
FORMER CONFORMED NAME: GLAUKOS CORP
DATE OF NAME CHANGE: 20020925
4
1
form4-03182024_110303.xml
X0508
4
2024-03-14
0001192448
GLAUKOS Corp
GKOS
0001920053
Navratil Tomas
C/O GLAUKOS CORPORATION
ONE GLAUKOS WAY
ALISO VIEJO
CA
92656
false
true
false
false
CHIEF DEVELOPMENT OFFICER
0
Common Stock
2024-03-14
4
A
0
1950
0
A
67546
D
Common Stock
2024-03-14
4
A
0
1027
0
A
68573
D
Common Stock
2024-03-14
4
A
0
11075
0
A
79648
D
Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 18, 2021, the earning and vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 14, 2024 that one of the operational targets had been achieved. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement of the operational target. 50% of the number of shares of common stock reported herein will vest and be delivered in March 2024 and the remaining 50% will vest and be delivered in December 2024.
Includes 49,736 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person.
Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 24, 2022, the earning and vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on March 14, 2024 that certain of the operational targets had been achieved. The number of shares of common stock reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. 50% of the number of shares of common stock reported herein will vest and be delivered in March 2024, and the remaining 50% will vest and be delivered in December 2024.
Includes 50,763 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person.
Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date.
Includes 61,838 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person.
Diana Scherer, Attorney-in-Fact
2024-03-18